nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Bexarotene—hematologic cancer	0.161	0.191	CbGbCtD
Sulfisoxazole—CYP2C9—Idarubicin—hematologic cancer	0.133	0.159	CbGbCtD
Sulfisoxazole—CYP2C9—Bortezomib—hematologic cancer	0.0987	0.117	CbGbCtD
Sulfisoxazole—CYP2C9—Thalidomide—hematologic cancer	0.0859	0.102	CbGbCtD
Sulfisoxazole—CYP2C9—Teniposide—hematologic cancer	0.082	0.0975	CbGbCtD
Sulfisoxazole—CYP2C9—Ifosfamide—hematologic cancer	0.0757	0.09	CbGbCtD
Sulfisoxazole—CYP2C9—Imatinib—hematologic cancer	0.0723	0.0859	CbGbCtD
Sulfisoxazole—CYP2C9—Nilotinib—hematologic cancer	0.0657	0.0781	CbGbCtD
Sulfisoxazole—CYP2C9—Cisplatin—hematologic cancer	0.0368	0.0438	CbGbCtD
Sulfisoxazole—CYP2C9—Dexamethasone—hematologic cancer	0.0297	0.0353	CbGbCtD
Sulfisoxazole—Sulfanilamide—CA9—hematologic cancer	0.000914	0.263	CrCbGaD
Sulfisoxazole—Sulfamethazine—ALB—hematologic cancer	0.000616	0.177	CrCbGaD
Sulfisoxazole—Dapsone—MPO—hematologic cancer	0.000614	0.177	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—hematologic cancer	0.000602	0.173	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—hematologic cancer	0.000467	0.134	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—ALB—hematologic cancer	0.000262	0.0754	CrCbGaD
Sulfisoxazole—CYP2C9—Biological oxidations—MTR—hematologic cancer	0.000187	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR5—hematologic cancer	0.000186	0.0012	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCR4—hematologic cancer	0.000186	0.00119	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—hematologic cancer	0.000185	0.00119	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEF1—hematologic cancer	0.000183	0.00118	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNA13—hematologic cancer	0.00018	0.00116	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL3—hematologic cancer	0.000179	0.00115	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—hematologic cancer	0.000178	0.00115	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TIAM1—hematologic cancer	0.000177	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—RASGRP1—hematologic cancer	0.000173	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL2—hematologic cancer	0.000172	0.00111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAK3—hematologic cancer	0.000171	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—hematologic cancer	0.000171	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCR4—hematologic cancer	0.000168	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—hematologic cancer	0.000167	0.00107	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL13—hematologic cancer	0.000164	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR7—hematologic cancer	0.000164	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL3—hematologic cancer	0.000162	0.00104	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCOR2—hematologic cancer	0.000162	0.00104	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CRKL—hematologic cancer	0.00016	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL3RA—hematologic cancer	0.00016	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RASGRP1—hematologic cancer	0.000157	0.00101	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GRB2—hematologic cancer	0.000156	0.001	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RGS2—hematologic cancer	0.000154	0.000993	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—hematologic cancer	0.000153	0.000984	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TRIO—hematologic cancer	0.000153	0.000982	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TRH—hematologic cancer	0.000153	0.000982	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CMA1—hematologic cancer	0.000153	0.000982	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGO2—hematologic cancer	0.000149	0.000961	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SPHK1—hematologic cancer	0.000149	0.000961	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HDAC9—hematologic cancer	0.000148	0.000951	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LPAR1—hematologic cancer	0.000148	0.000951	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H3F3B—hematologic cancer	0.000146	0.000942	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—hematologic cancer	0.000142	0.000911	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GRB2—hematologic cancer	0.000141	0.000909	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CSF2—hematologic cancer	0.000139	0.000894	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000137	0.000881	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CNR2—hematologic cancer	0.000136	0.000876	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4B—hematologic cancer	0.000136	0.000876	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hematologic cancer	0.000136	0.000872	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF19—hematologic cancer	0.000135	0.000868	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—JAK1—hematologic cancer	0.000134	0.000863	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCG—hematologic cancer	0.000134	0.000863	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAC2—hematologic cancer	0.000134	0.000861	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—DKK1—hematologic cancer	0.000133	0.000855	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT5B—hematologic cancer	0.000132	0.000848	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADCY7—hematologic cancer	0.000128	0.000823	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2—hematologic cancer	0.000126	0.000812	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2RA—hematologic cancer	0.000125	0.000806	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—XIAP—hematologic cancer	0.000124	0.000801	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—hematologic cancer	0.000123	0.000794	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—JAK1—hematologic cancer	0.000122	0.000784	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCG—hematologic cancer	0.000122	0.000784	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—hematologic cancer	0.000122	0.000783	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SH2B3—hematologic cancer	0.000121	0.00078	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SMARCA4—hematologic cancer	0.000121	0.00078	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GZMB—hematologic cancer	0.000121	0.000776	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNA1—hematologic cancer	0.000118	0.000757	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000117	0.000753	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HSPB1—hematologic cancer	0.000117	0.000753	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL3—hematologic cancer	0.000117	0.000753	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SDC1—hematologic cancer	0.000116	0.000744	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTHLH—hematologic cancer	0.000116	0.000744	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2RA—hematologic cancer	0.000114	0.000732	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—hematologic cancer	0.000113	0.00073	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTGER4—hematologic cancer	0.000113	0.000725	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LCK—hematologic cancer	0.000112	0.000721	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—hematologic cancer	0.000112	0.00072	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000112	0.000718	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H3F3A—hematologic cancer	0.00011	0.000707	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCZ—hematologic cancer	0.000107	0.000687	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000104	0.000672	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PARP1—hematologic cancer	0.000103	0.000664	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FBXW7—hematologic cancer	0.000101	0.000653	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HDAC2—hematologic cancer	9.95e-05	0.00064	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR4—hematologic cancer	9.95e-05	0.00064	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	9.76e-05	0.000628	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CBL—hematologic cancer	9.7e-05	0.000624	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL3—hematologic cancer	9.6e-05	0.000617	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—hematologic cancer	9.48e-05	0.00061	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PHYH—hematologic cancer	9.46e-05	0.000609	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GMPS—hematologic cancer	9.46e-05	0.000609	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FTCD—hematologic cancer	9.46e-05	0.000609	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTPN1—hematologic cancer	9.43e-05	0.000607	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	9.37e-05	0.000602	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PTPN11—hematologic cancer	9.31e-05	0.000599	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RASGRP1—hematologic cancer	9.28e-05	0.000597	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HSP90AA1—hematologic cancer	9.25e-05	0.000595	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SYK—hematologic cancer	9.25e-05	0.000595	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—hematologic cancer	9.18e-05	0.00059	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CREB1—hematologic cancer	9.02e-05	0.00058	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	8.92e-05	0.000574	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT1—hematologic cancer	8.92e-05	0.000574	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—hematologic cancer	8.83e-05	0.000568	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	8.82e-05	0.000568	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6R—hematologic cancer	8.8e-05	0.000566	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3R1—hematologic cancer	8.67e-05	0.000557	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SMPD3—hematologic cancer	8.65e-05	0.000557	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	8.63e-05	0.000555	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—JAK2—hematologic cancer	8.42e-05	0.000542	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAP2K1—hematologic cancer	8.39e-05	0.00054	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GRB2—hematologic cancer	8.35e-05	0.000537	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—hematologic cancer	8.33e-05	0.000536	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFA—hematologic cancer	8.33e-05	0.000536	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KITLG—hematologic cancer	8.21e-05	0.000528	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	8.07e-05	0.000519	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT5A—hematologic cancer	8.02e-05	0.000516	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—hematologic cancer	8e-05	0.000515	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN2B—hematologic cancer	7.95e-05	0.000511	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3R1—hematologic cancer	7.87e-05	0.000506	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	7.86e-05	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD86—hematologic cancer	7.69e-05	0.000495	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—JAK2—hematologic cancer	7.65e-05	0.000492	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HES1—hematologic cancer	7.59e-05	0.000488	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DCK—hematologic cancer	7.56e-05	0.000487	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ASNS—hematologic cancer	7.56e-05	0.000487	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—B3GAT1—hematologic cancer	7.56e-05	0.000487	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCOR1—hematologic cancer	7.54e-05	0.000485	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF1—hematologic cancer	7.46e-05	0.00048	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—hematologic cancer	7.46e-05	0.00048	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	7.39e-05	0.000476	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FOXO1—hematologic cancer	7.35e-05	0.000473	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—hematologic cancer	7.35e-05	0.000473	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFRB—hematologic cancer	7.34e-05	0.000472	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—hematologic cancer	7.26e-05	0.000467	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFRA—hematologic cancer	7.22e-05	0.000465	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCG—hematologic cancer	7.2e-05	0.000463	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAK1—hematologic cancer	7.2e-05	0.000463	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HDC—hematologic cancer	7.17e-05	0.000461	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2RA—hematologic cancer	6.72e-05	0.000432	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	6.69e-05	0.00043	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—hematologic cancer	6.67e-05	0.000429	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—hematologic cancer	6.65e-05	0.000428	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CDA—hematologic cancer	6.56e-05	0.000422	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFB—hematologic cancer	6.49e-05	0.000417	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TSC2—hematologic cancer	6.34e-05	0.000408	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PC—hematologic cancer	6.31e-05	0.000406	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR3—hematologic cancer	6.1e-05	0.000392	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GBA—hematologic cancer	6.1e-05	0.000392	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC35B2—hematologic cancer	6.1e-05	0.000392	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK14—hematologic cancer	6.04e-05	0.000388	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—hematologic cancer	5.92e-05	0.000381	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—hematologic cancer	5.85e-05	0.000376	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BAD—hematologic cancer	5.78e-05	0.000372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NFKBIA—hematologic cancer	5.78e-05	0.000372	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—hematologic cancer	5.73e-05	0.000368	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CD80—hematologic cancer	5.61e-05	0.000361	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—hematologic cancer	5.6e-05	0.00036	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIT—hematologic cancer	5.6e-05	0.00036	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NRAS—hematologic cancer	5.6e-05	0.00036	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTAP—hematologic cancer	5.58e-05	0.000359	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTPN11—hematologic cancer	5.5e-05	0.000354	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK3—hematologic cancer	5.36e-05	0.000345	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREB1—hematologic cancer	5.33e-05	0.000343	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—hematologic cancer	5.26e-05	0.000339	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—hematologic cancer	5.22e-05	0.000336	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6R—hematologic cancer	5.2e-05	0.000335	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREBBP—hematologic cancer	5.19e-05	0.000334	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FHL2—hematologic cancer	4.97e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAP2K1—hematologic cancer	4.96e-05	0.000319	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—hematologic cancer	4.92e-05	0.000317	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—hematologic cancer	4.88e-05	0.000314	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AGRN—hematologic cancer	4.87e-05	0.000314	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—hematologic cancer	4.82e-05	0.00031	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF2—hematologic cancer	4.71e-05	0.000303	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3R1—hematologic cancer	4.65e-05	0.000299	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—IDH2—hematologic cancer	4.62e-05	0.000297	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMMR—hematologic cancer	4.62e-05	0.000297	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAK2—hematologic cancer	4.52e-05	0.000291	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—hematologic cancer	4.43e-05	0.000285	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—hematologic cancer	4.41e-05	0.000284	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.36e-05	0.00028	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ARNTL—hematologic cancer	4.34e-05	0.000279	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—hematologic cancer	4.29e-05	0.000276	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MTOR—hematologic cancer	4.29e-05	0.000276	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACP5—hematologic cancer	4.23e-05	0.000272	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA9—hematologic cancer	4.23e-05	0.000272	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOR2—hematologic cancer	4.17e-05	0.000268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—hematologic cancer	4.1e-05	0.000264	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1B—hematologic cancer	4.03e-05	0.000259	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—hematologic cancer	3.98e-05	0.000256	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—IDH1—hematologic cancer	3.97e-05	0.000256	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—hematologic cancer	3.95e-05	0.000254	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—hematologic cancer	3.94e-05	0.000254	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTO1—hematologic cancer	3.93e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TXN—hematologic cancer	3.93e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCC3—hematologic cancer	3.93e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—hematologic cancer	3.92e-05	0.000252	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SPHK1—hematologic cancer	3.85e-05	0.000247	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—hematologic cancer	3.84e-05	0.000247	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUN—hematologic cancer	3.83e-05	0.000247	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—hematologic cancer	3.72e-05	0.000239	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—hematologic cancer	3.71e-05	0.000239	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UGT1A1—hematologic cancer	3.69e-05	0.000238	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK8—hematologic cancer	3.63e-05	0.000233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—hematologic cancer	3.62e-05	0.000233	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC22A1—hematologic cancer	3.59e-05	0.000231	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CRABP1—hematologic cancer	3.59e-05	0.000231	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EP300—hematologic cancer	3.54e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.5e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SRC—hematologic cancer	3.44e-05	0.000221	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NUP98—hematologic cancer	3.39e-05	0.000218	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—hematologic cancer	3.35e-05	0.000215	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—hematologic cancer	3.32e-05	0.000213	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRAS—hematologic cancer	3.31e-05	0.000213	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.29e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.29e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NUP214—hematologic cancer	3.27e-05	0.00021	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.24e-05	0.000208	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTR—hematologic cancer	3.2e-05	0.000206	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.2e-05	0.000206	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK3—hematologic cancer	3.17e-05	0.000204	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO2—hematologic cancer	3.14e-05	0.000202	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—hematologic cancer	3.08e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—hematologic cancer	3.07e-05	0.000198	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.05e-05	0.000196	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3e-05	0.000193	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SDC1—hematologic cancer	2.98e-05	0.000192	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—hematologic cancer	2.85e-05	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.84e-05	0.000183	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.81e-05	0.000181	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.69e-05	0.000173	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—hematologic cancer	2.62e-05	0.000168	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CD44—hematologic cancer	2.53e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NQO1—hematologic cancer	2.53e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—hematologic cancer	2.53e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.48e-05	0.000159	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—hematologic cancer	2.42e-05	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYCS—hematologic cancer	2.4e-05	0.000154	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.38e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—hematologic cancer	2.32e-05	0.000149	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.14e-05	0.000138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—hematologic cancer	2.14e-05	0.000137	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.11e-05	0.000136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.04e-05	0.000131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—hematologic cancer	2e-05	0.000129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOR1—hematologic cancer	1.94e-05	0.000125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—hematologic cancer	1.94e-05	0.000125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.72e-05	0.00011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.51e-05	9.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.44e-05	9.27e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.34e-05	8.59e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.27e-05	8.15e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—hematologic cancer	1.25e-05	8.04e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.2e-05	7.69e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.1e-05	7.1e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—hematologic cancer	9.54e-06	6.14e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EP300—hematologic cancer	9.1e-06	5.85e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—hematologic cancer	6.73e-06	4.33e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—hematologic cancer	5.5e-06	3.54e-05	CbGpPWpGaD
